Evidence map›Paper›PMID 36373469›Full record

Trial reportJournal of Korean Academy of Nursing2022

[The Development of Automated Personalized Self-Care (APSC) Program for Patients with Type 2 Diabetes Mellitus].

Gaeun Park, Haejung Lee, Ah Reum Khang

Abstract readRandomized Controlled TrialEnglish Abstract
PubMed Publisher
In one paragraph

Trial report in Journal of Korean Academy of Nursing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gaeun ParkCollege of Nursing, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0000-0003-0923-4340
Haejung LeeCollege of Nursing, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0000-0003-0291-9945
Ah Reum KhangDepartment of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.ORCID https://orcid.org/0000-0002-9154-6468

Funding

National Research Foundation of Korea NRF-2019R1I1A3A01062513
6 · The paper itself

Abstract

purposeThe study aimed to design and develop an automated personalized self-care (APSC) program for patients with type 2 diabetes mellitus. The secondary aim was to present a clinical protocol as a mixed-method research to test the program effects.

methodsThe APSC program was developed in the order of analysis, design, implementation, and evaluation according to the software development life cycle, and was guided by the self-regulatory theory. The content validity, heuristics, and usability of the program were verified by experts and patients with type 2 diabetes mellitus.

resultsThe APSC program was developed based on goal setting, education, monitoring, and feedback components corresponding to the phases of forethought, performance/volitional control, and self-reflection of self-regulatory theory. Using the mobile application, the participants are able to learn from educational materials, monitor their health behaviors, receive weekly-automated personalized goals and feedback messages, and use an automated conversation system to solve the problems related to self-care. The ongoing two-year study utilizes a mixed method design, with 180 patients having type 2 diabetes mellitus randomized to receive either the intervention or usual care. The participants will be reviewed for self-care self-efficacy, health behaviors, and health outcomes at 6, 12, 18, and 24 months. Participants in the intervention group will be interviewed about their experiences.

conclusionThe APSC program can serve as an effective tool for facilitating diabetes health behaviors by improving patients' self-care self-efficacy and self-regulation for self-care. However, the clinical effectiveness of this program requires further investigation.

Indexed as

Diabetes Mellitus, Type 2Mobile ApplicationsHumansSelf CareSelf EfficacySemicarbazones2-acetylpyridine semicarbazoneSemicarbazonesAutomationDiabetes Mellitus, Type 2Mobile ApplicationsSelf-ControlSelf-Management

Identifiers

PMID36373469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.